Company News, New Products

Tylenol Precise is Kenvue’s First US Product Launch Since Its Publicly Traded Status

Gel cream topical offers maximum strength lidocaine without a prescription.

Kenvue, a Happi Top 50 Company, has announced its first US product launch since it became publicly traded.    Tylenol Precise builds on “decades of science innovation brought about by consumer-led insights,” said the company.   Tylenol created a gel cream topical to provide maximum strength lidocaine (4%) without a prescription. The massaging rollerball applicator delivers targeted pain relief. The development of this product also addresses a need for the brand—i...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters